“Exploring New Hope for Children with Cow's Milk Allergy: The Viaskin Milk Trial”

For parents managing their child’s cow’s milk allergy (CMA), a new clinical trial offers hope. Published in JAMA Pediatrics, the study investigates Viaskin Milk, a patch that delivers small doses of milk protein through the skin to build tolerance. Results from the trial, which involved 198 children, show that the 300 μg dose of Viaskin Milk was most effective, with 49% of children demonstrating increased milk tolerance after 12 months. The study also highlights promising results for younger children and confirms the safety of this treatment, with most side effects being mild. While more research is needed, Viaskin Milk could become a game-changing option for families dealing with CMA.